Axsome Therapeutics
AXSM
AXSM
17 hedge funds and large institutions have $44.9M invested in Axsome Therapeutics in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.79M | |
| 2 | +$269K | |
| 3 | +$114K | |
| 4 |
Morgan Stanley
New York
|
+$111K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$103K |
Top Sellers
| 1 | -$954K | |
| 2 | -$629K | |
| 3 | -$517K | |
| 4 |
Goldman Sachs
New York
|
-$226K |
| 5 |
Bank of New York Mellon
New York
|
-$107K |